Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Clayton Rowland
Observed names:
C Rowland,
C T Rowland,
C. Rowland
Institution:
Pfizer (United States)
Observed institutions:
University of Minnesota,
Pfizer (United States),
Icahn School of Medicine at Mount Sinai
OpenAlex ID:
A5111477551
Obsessive-compulsive and spectrum disorders: overview and quality of life issues.
1996
·
E Hollander
, J H Kwon
, et al.
·
PubMed
·
365
Psychosocial Function and Economic Costs of Obsessive-Compulsive Disorder
1997
·
Eric Hollander
, Dan J. Stein
, et al.
·
CNS Spectrums
·
158
Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis
1979
·
J. Lyle Bootman
, Albert I. Wertheimer
, et al.
·
Journal of Pharmaceutical Sciences
·
105
Psychosocial Function and Economic Costs of Obsessive-Compulsive Disorder
1998
·
Eric Hollander
, Dan J. Stein
, et al.
·
CNS Spectrums
·
73
Cost Effectiveness of Pramipexole in Parkinson??s Disease in the US
1998
·
Thomas J. Hoerger
, Mohan V. Bala
, et al.
·
PharmacoEconomics
·
50
The impact of antidepressant use on social functioning: reboxetine versus fluoxetine
2000
·
L. N. Venditti
, A. Arcelus
, et al.
·
International Clinical Psychopharmacology
·
22
The impact on employment of an intervention to increase recognition of previously untreated anxiety among primary care physicians
1996
·
Edward Yelin
, Susan D. Mathias
, et al.
·
Social Science & Medicine
·
18
Cost of individualizing aminoglycoside dosage regimens
1979
·
J. Lyle Bootman
, Darwin E. Zaske
, et al.
·
American Journal of Health-System Pharmacy
·
17
Cost-Benefit Analysis: A Research Tool for Evaluating Innovative Health Programs
1979
·
J. Lyle Bootman
, Clayton Rowland
, et al.
·
Evaluation & the Health Professions
·
14
Pmh15: Economic Evaluation of Reboxetine for Treating Major Depression
2000
·
SK Sheriff
, HP Levaux
, et al.
·
Value in Health
PDF
Pnp9: Antidepressant Impact on Social Functioning: Reboxetine Versus Fluoxetine
1999
·
LN Venditti
, A Arcelus
, et al.
·
Value in Health
PDF
Pn7: Cost-effectiveness of Pramipexole in Parkinson's Disease in Three Countries
1999
·
T Hoerger
, M Bala
, et al.
·
Value in Health
Show more works
View as search
Works count:
12
Citation count:
822
H-index:
9
I10-index:
9
Year
Topic
Type